Beam Therapeutics Средняя величина рекомендации
Что обозначает Средняя величина рекомендации в Beam Therapeutics?
Средняя величина рекомендации Beam Therapeutics Inc. является 1.80
Какое определение для Средняя величина рекомендации?
Средняя величина рекомендации является средним значением рейтингов аналитиков от 1,0 (активно покупать) до 5,0 (активно продавать).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Средняя величина рекомендации компаний в Health Care сектор на NASDAQ по сравнению с Beam Therapeutics
Что делает Beam Therapeutics?
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Компании с средняя величина рекомендации похож на Beam Therapeutics
- Linde Plc имеет Средняя величина рекомендации из 1.79
- Quest Diagnostics имеет Средняя величина рекомендации из 1.79
- Skyworks Solutions имеет Средняя величина рекомендации из 1.79
- DocuSign Inc имеет Средняя величина рекомендации из 1.79
- Monster Beverage имеет Средняя величина рекомендации из 1.79
- Digital Realty Trust Inc имеет Средняя величина рекомендации из 1.79
- Beam Therapeutics имеет Средняя величина рекомендации из 1.80
- Darden Restaurants имеет Средняя величина рекомендации из 1.81
- Brunswick имеет Средняя величина рекомендации из 1.81
- Revolve Inc имеет Средняя величина рекомендации из 1.81
- Targa Resources Corp имеет Средняя величина рекомендации из 1.81
- Astrazeneca plc имеет Средняя величина рекомендации из 1.81
- Planet Fitness Inc имеет Средняя величина рекомендации из 1.81